CRATERs identified as key sites for T cell-mediated tumor destruction
Like the surface of the moon, new research published today in Cell finds the existence of craters on…
Scalable synthetic biology revolutionizes targeted therapy with logic-gate proteins
Targeted drug delivery is a powerful and promising area of medicine. Therapies that pinpoint the exact areas of…
UCSF team uncovers breakthrough immunotherapy for colon cancer liver metastases
Advanced colon cancer is the leading cause of cancer-related death in young American men and the second highest…
Engineered Salmonella therapy delivers immune payloads to combat cancer
A new research paper was published in Volume 16 of Oncotarget on October 6, 2025, titled “ACTM-838, a novel systemically delivered…
Novel treatment disrupts tumor immunosuppression in pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a five-year survival rate below 10%. University…
Study identifies immune biomarkers for personalized therapies in pediatric germ cell tumors
A study conducted by the Molecular Oncology Research Center (CPOM) at Hospital de Amor in Barretos (formerly Barretos…
New findings show lymph nodes educate T cells to combat disease
A team of researchers, led by the Peter Doherty Institute for Infection and Immunity (Doherty Institute), explored the…
Scientists Find a Way to “Bulletproof” T Cells Against Cancer
Researchers at the University of Pittsburgh have discovered that the harsh environment inside tumors, characterized by low oxygen…
A single genetic mutation may have made humans more vulnerable to cancer than chimpanzees
(SACRAMENTO) New research from UC Davis Comprehensive Cancer Center has uncovered an evolutionary change that may explain why…
Adjuvant chemo-immunotherapy may benefit patients with resected stage IB–IIIA NSCLC, trial suggests
Interim results from the NADIM ADJUVANT Phase III trial, led by the Spanish Lung Cancer Group (GECP), suggest…